Table 5 Relationship of TREML4 polymorphisms with subclinical Atherosclerosis (SA).

From: TREML4 polymorphisms increase the mRNA in blood leukocytes in the progression of atherosclerosis

Polymorphism

 

Control

SA

p-value

rs2803495 A/G

N = 325

N = 127

N = 198

Genotypes (%)

AA

82.2 (267)

82.7 (105)

81.8 (162)

0.844

(Codominant)

AG

17.8 (58)

17.3 (22)

18.2 (36)

GG

0 (0)

0

0

(Dominant)

AA

82.2 (267)

82.7 (105)

81.8 (162)

0.844

AG + GG

17.8 (58)

17.3 (22)

18.2 (36)

Alleles (%)

A

100 (325)

100 (125)

100 (198)

0.911

G

17.8 (58)

17.3 (22)

18.2 (36)

rs2803496 C/T

N = 324

N = 125

N = 199

 

Genotypes (%)

TT

82.2 (262)

83.2 (104)

79.4 (158)

0.369

(Codominant)

CT

17.0 (55)

16.0 (20)

17.6 (35)

CC

2.2 (7)

0.8 (1)

3.0 (6)

(Dominant)

TT

80.9 (262)

83.2 (104)

79.4 (158)

0.397

CT + CC

19.1 (62)

16.8 (21)

20.6 (41)

Alleles (%)

T

97.83 (317)

99.2 (124)

96.9 (193)

0.437

C

19.13 (62)

16.8 (21)

20.60 (41)

  1. Number of subjects in parenthesis. Frequencies were compared by the Chi-Squared test. p-values refer to comparisons among genotype frequencies of the different models and among allelic frequencies. < 10% of all samples did not have their genotype detected. SA-Subclinical Atherosclerosis.